A little affirmative action in the funding of research into rare cancers could go a long way, according to a new report from Rare Cancers Australia. The report, launched at their recent CanForum17, calls for a redistribution of research funds to build the evidence necessary to underpin the registration and reimbursement of new therapies. Professor David ...
The only thing standing in the way of rare cancer is funding
By Mardi Chapman
14 Aug 2017